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a b s t r a c t
Background: Orodispersible tablets or fast dissolving tablets dissolve or disintegrate imme-
diately on the patients’ tongue or buccal mucosa. This drug delivery system is suitable for
drugs undergoing high ﬁrst pass metabolism. It improves bioavailability, reduces dosing
frequency, and thereby minimizes the side effects and also makes the dosage form more
cost-effective. In this study, polysaccharide isolated from the seeds of Cassia tora was inves-
tigated as a superdisintegrant in the orodispersible tablets. The model drug chosen was
valsartan, an antihypertensive drug.
Methods:Valsartan tabletswereprepared separately usingdifferent concentrations (1%, 2.5%,
5%, and 7.5% w/w) of isolated C. tora seed polysaccharide (natural) and sodium starch glyco-
late (synthetic) as superdisintegrant by the direct compressionmethod. Evaluation of tablets
was done for various pre- and postcompression parameters. The stability studies were per-
formed on optimized formulation F4. The disintegration time and in vitro drug release of the
formulation F4 were compared with marketed formulations (conventional tablets).
Results: The drug excipient interactions were characterized by Fourier transform infrared
studies. The formulation F4 containing 7.5% polysaccharide showed good wetting time
and disintegration time as compared to a formulation prepared using a synthetic super-
disintegrant at the same concentration level. Hence, batch F4 was considered optimized
formulation.
Conclusion: The present work revealed that C. tora seed polysaccharide has a good potential
as a disintegrant in the formulation of orodispersible tablets. Because C. tora polysaccharideis inexpensive as compared to synthetic superdisintegrants, nontoxic, compatible, and easy
to manufacture, it can be used in place of currently marketed superdisintegrants.
© 2014 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license∗ Corresponding author. Department of Quality Assurance, Dr. L. H. Hir
tation,Ulhasnagar 421003, Maharashtra, India.
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1. Introduction
Tablets and capsules are themost extensively used andwidely
acceptable dosage forms. However, they face a drawback for
some patients because of the difﬁculty to swallow. Tablets
that dissolve rapidly in the oral cavity have become very pop-
ular in recent times. Orodispersible tablets (ODTs) represent
a rapidly emerging drug delivery system with better patient
compliance. ODTs are used for people who have swallowing
difﬁculties as well as for active people.1–3
ODTs disintegrate in the patient’s mouth within a few
seconds and are ideal for patients having dysphasia.4,5 Some
drugs are absorbed from the mouth, pharynx, and esopha-
gus as the saliva passes down the stomach, which leads to an
increase in bioavailability. The advantages of mouth dissolv-
ing dosage form are increasingly being acknowledged in both
industry and academia.6 ODTs are commonly known as orally
disintegrating tablets, mouth dissolving tablets, fast dissolv-
ing tablets, or rapid melt tablets.
The additives used to convert active pharmaceutical
ingredients into pharmaceutical dosage form are known
as excipients.7 Excipients from natural sources have an
advantage over synthetic excipients in that they are locally
accessible, nonpolluting, biocompatible, and cheap as com-
pared to imported synthetic products. Herbs are renewable
resources for maintainable supplies of cheaper pharmaceu-
tical products.8–15
Fast disintegrating tablets are made by a direct com-
pression method using superdisintegrants as an important
component. Disintegrants are the substances or mixture of
substances added to the drug formulation that helps in the
disintegration of the tablet content into smaller particles
that dissolve more rapidly than tablets without disintegrants.
Examples of superdisintegrants are croscarmelose, crospovi-
done, and sodium starch glycolate (SSG), which symbolize the
example of crosslinked cellulose, crosslinked polymer, and a
crosslinked starch, respectively.16,17 These are the commonly
used synthetic origin superdisintegrants. Various natural ori-
gin substances such as karaya, modiﬁed starch, and agar
have been used in the formulations of ODTs. The natural
origin substances are comparatively cheaper with certain
desired properties such as abundantly available, nonirritating,
and nontoxic in nature.19 They have several advantages over
synthetic superdisintegrants, such as ease of isolation, local
availability, and biocompatibility.
Cassia tora (Family: Leguminosae) is an annual under shrub
commonly found in India and other tropical countries.20 Seeds
of C. tora contain several anthraquinones and sennosoids.21–23
It has beenused for treatment of asthmaand to improve visual
activity.24 It has anti-inﬂammatory and hepatoprotective
activities.25 Gum obtained from the seeds of C. tora is known
as “Panwar gum”. Chemically, it is a neutral heteropolysac-
charide of galactose and mannose (i.e., galactomannans). The
pH of the Panwar gum mucilage is approximately 7.20 A liter-
ature survey revealed that the C. tora polysaccharide has not
been used to date as a disintegrant, and hence this polysac-
charidewas selected for thepresent investigation. Thepresent
study deals with the investigation of a polysaccharide isolated
from the seeds of C. tora as a superdisintegrant in ODTs andIntegr Med Res ( 2 0 1 4 ) 91–98
compares its disintegrating potential with synthetic superdis-
integrants.
The model drug used for the study was valsartan, which
is an antihypertensive drug belonging to the category of
angiotensin II receptor antagonist. The molecular weight of
valsartan is 435.5, and its half-life is 4–6hours; it has poor
oral bioavailability (ranging from 10 to 35), because of poor
solubility, dissolution, 95% of the drug undergoes protein
binding, and most importantly extensive ﬁrst pass hepatic
metabolism.26,27 The present research work was aimed at the
development and characterization of ODTs of valsartan using




Valsartan was obtained from Unichem Laboratories Ltd.,
Mumbai, India as a gift sample. Microcrystalline cellulose
(MCC PH 102), SSG, magnesium stearate, talc, aspartame,
and vanilla ﬂavor were obtained from Colorcon Asia Pvt. Ltd.
(Mumbai, India). C. tora seeds were collected from the Maha-
rashtra region (India) in the month of October. The plant
material was authenticated at the Blatter herbarium. The
specimen sample of the plant is preserved with the Depart-
ment of Quality Assurance, Dr. L.H. Hiranandani College of
Pharmacy, Ulhasnagar, India. All chemicals and reagents used
in this study were of analytical grade.
2.2. Isolation of polysaccharide from C. tora seeds
The seeds of C. tora were dry milled in a mixer to separate
the endosperm from the seed coat. The endosperm of C. tora
seeds (100 g) was soaked in distilled water and shaken for
4–5hours. The viscous solution obtained was ﬁltered through
a muslin cloth. Precipitation of the mucilage (polysaccharide)
was carried out with the addition of 95% ethanol (1:1 ratio)
by continuous stirring. The precipitated polysaccharide was
transferred to an evaporating dish and treated consecutively
with ethanol. The polysaccharide obtained was dried in oven
at 40–45 ◦C. It was then powdered and passed through sieve
number 60 and stored in an airtight container. The isolated
polysaccharide was characterized for various physicochemi-
cal properties such as solubility, pH (1%w/w inwater), swelling
index, loss on drying, ash value, bulk and tapped density, com-
pressibility index, Hausner’s ratio, and angle of repose as per
the reported method.28,29
2.3. Formulation of ODTs
ODTs of valsartan were prepared with the direct compression
method using isolated polysaccharide and synthetic superdis-
integrant at concentrations of 1%, 2.5%, 5%, and 7.5% w/w.
All the ingredients were passed through a 60 mesh sieve.
A weighed quantity of each ingredient was taken, and the
blend (powdermix)wasuniformlymixedand compressed into
tablets of 200mg using 9-mm round ﬂat punches on a single
H. Pawar et al/Seed polysaccharide as a superdisintegrant 93
Table 1 – Composition of orodispersible tablet
Components mg/tablet Formulation code
F1 F2 F3 F4 F5 F6 F7 F8
Drug 40 40 40 40 40 40 40 40
Microcrystalline cellulose PH102 151.2 148.2 143.2 138.2 151.2 148.2 143.2 138.2
Cassia tora polysaccharide 2 5 10 15 – – – –
Sodium starch glycolate – – – – 2 5 10 15
Aspartame 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8








































Magnesium stearate 2 2
Total weight 200 200
tation rotary tabletmachine (Royal artist,Mumbai, India). The
omposition of each formulation is given in Table 1.
.4. Evaluation of powder blend (precompression
arameters)
he powder mix was evaluated for various ﬂow properties
uch as angle of repose, bulk and tapped density, Hausner’s
atio, and Carr’s index.
.4.1. Angle of repose
he angle of repose of powder was carried out using the ﬁxed
unnel method. The accurately weighed quantity of powder
ix was taken in a funnel. The height of the funnel wasmain-
ained in such a way that the tip of the funnel just touched
he apex of the heap of the powder. The powder was allowed
o ﬂow through the funnel without any resistance on to the
urface. Thediameter andheight of thepowder conewasmea-
ured. The angle of reposewas determined using the following
quation:
an  = h/r,
here h and r are the height and radius of the powder cone,
espectively.
.4.2. Bulk density and tapped density
owder weighing 5g from each formula was introduced into
25-mL measuring cylinder. It was initially shaken lightly to
reak any agglomerates thatmay have formed. The initial vol-
me was noted, and the cylinder was allowed to fall under its
wn weight onto a hard surface from the height of 2.5 cm at
-second intervals. The tapping was continued until a con-
tant volume was observed.30 LBD (Loose bulk density) and
BD (Tapped bulk density) were calculated using the following
ormulas:
BD = Weight of thepowder/volumeof thepacking
BD = Weight of thepowder/tappedvolumeof thepacking
.4.3. Compressibility index and Hausner’s ratio
he following formula was used to determine the compress-
bility index of granules:
arr’s compressibility index (Carr’s index) = [(TBD − LBD) × 100]/TBD1 1 1 1 1
2 2 2 2 2
200 200 200 200 200
Hausner’s ratio was calculated by the following formula:
Hausner’s ratio = Tappeddensity/Bulkdensity
2.5. Evaluation of tablets (postcompression
parameters)
2.5.1. Tablet hardness
Hardness is a vital parameter that prevents breakage of tablets
during transportation, handling, and storage. The hardness of
tablet was measured with the Monsanto hardness tester and
was expressed in terms of kg/cm2.
2.5.2. Tablet thickness
The tablet was placed between the two arms of the Vernier
caliper, and thickness was determined. Five measurements
were taken.
2.5.3. Weight variation
Twenty tabletswere selected arbitrarily fromeach formulation
and weighed individually using a digital balance (Shimadzu
Corporation, Japan; Model No. BL 220H). The individual
weights were noted and compared with the average weight
for the weight variation.31
2.5.4. Friability
Twenty tablets were weighed and then placed in a plastic
chambered friabilator USP type Roche friabilator (Pharmalab,
Ahmedabad, India) attached to a motor revolving at a speed
of 25 rpm for 4minutes. The tablets were reweighed, and the
percentage weight loss (friability) was calculated using the
following formula:
Friability = [(Initialweight − Finalweight)/(Initialweight)] × 100%.
2.5.5. Drug content
Ten tablets were weighed and crushed to a ﬁne powder, and
a quantity of powder equivalent to 40mg of valsartan was
introduced into a 100-mL volumetric ﬂask and extracted using
pH 6.8 phosphate buffer. The solution obtained was ﬁltered,
and the ﬁltrate was suitably diluted with pH 6.8 phosphate
buffer. The valsartan content was determined by measuring
the absorbance at 250nmusing aUV–Visible Spectrophotome-
ter (UV-1800 with UV–Probe Version 2.34 software, Shimadzu
Corporation, Japan). The drug content was determined using
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Solubility Soluble in hot water forming
colloidal solution insoluble in
organic solvent
Swelling factor 11.5 mL
Practical yield 18.56% w/w
Total ash 1.47
Moisture content 1.2%
Total polysaccharide content 72.12% w/w
Angle of repose 29.24◦
Bulk density 0.64 g/cm3
3
(aliphatic) at 2962.66 cm−1, N–H stretch at 3444.87 cm−1,
carboxylic acid stretch at 1732.08 cm−1, C=O stretch at
1600.02 cm−1, and C–N stretch at 1273.02 cm−1, 1205.51 cm−1,94
the standard calibration curve.32 The mean percent drug con-
tent was calculated as an average of three determinations.
2.5.6. Wetting time and water absorption ratio (R)
A tissue paper was taken and folded twice and placed in a
Petri dish (with an internal diameter of 5 cm) containing 6mL
of water. A tablet was cautiously placed on the top of the tis-
sue paper in the Petri dish. Wetting time was noted as the
time required for water to reach the upper surface of the tablet
and to completely wet it.33 Water absorption ratio (R) was then
determined according to the following equation:
R = 100 × (wa − wb)/wb,
where wb and wa denote the tablet weights before and after
water absorption, respectively.
2.5.7. In vitro disintegration time
The tablet disintegration test apparatuswasused todetermine
the disintegration time for all formulations. Six tablets were
placed individually in each tube of disintegration test appara-
tus. Themediumwasmaintainedat a temperature of 37±2 ◦C,
and the time was noted for the entire tablet to disintegrate
completely.
2.5.8. In vitro dissolution
The USP dissolution test apparatus (Electrolab TDT - 08 L Dis-
solution testers USP) type 2 (paddle) was used for the study.
First, 900mL of the phosphate buffer pH 6.8 was taken in a
vessel, and the temperaturewasmaintained at 37±0.5 ◦C. The
speed of the paddle was ﬁxed at 50 rpm. Dissolution samples
were withdrawn at 2-minute intervals, and drug content was
determined by measuring the absorbance at 250nm.34 Drug
concentration was calculated from the standard calibration
curve and expressed as cumulative percent drug dissolved.
In vitro dissolution study was also performed similarly on a
conventional tablet formulation (Valzaar, Torrent Pharmaceut-
icals Ltd., India).
2.5.9. Drug–excipient interaction study
The pure drug, mixture of drug with polysaccharide (1:1), and
the optimized formulations (mixture of drug with various
excipients used in the preparation of ODT formulation) were
characterized by Fourier transform infrared spectroscopy so
the compatibility can be determined. The scanning range was
500–4000 cm–1 and the IR spectra of samples were obtained
using the KBr disk method.
2.5.10. Stability studies
The stability study of the tablets was carried out by keep-
ing the samples in the stability chamber at 40±20 ◦C/75±5%
RH for 3 months as per the ICH (International Conference on
Harmonisation of Technical Requirements for Registration of
Pharmaceuticals for Human Use) guidelines. The optimized
batch was selected for stability studies. The tablets were
evaluated for hardness, friability, drug content (Assay), disin-
tegration time, and in vitro drug release proﬁle after a 1-month




The polysaccharide isolated from C. tora seeds was a light
brown colored powder (yield=18.56% w/w). The polysaccha-
ride was soluble in hot water forming a colloidal solution and
practically insoluble in organic solvents. The pH of 1% w/w
solution of polysaccharide was found to be near neutral. The
polysaccharide showed good swelling and water absorption
capacity. The Carr’s index and angle of repose indicated that
the polysaccharide has a good ﬂow with moderate compress-
ibility. The losses on drying and ash values were well within
ofﬁcial limits. The results of the physicochemical characteri-
zation of polysaccharide are reported in Table 2.
Drug–excipient interaction studies revealed that there was
no physicochemical interaction between valsartan and other
excipients (Fig. 1). All the major peaks of valsartan were
found in the sample. The functional peaks include C–H stretchFig. 1 – Fourier transform infrared spectrum of (A) pure
drug, (B) pure drug + polysaccharide, and (C) optimized
formulation F4.
H. Pawar et al/Seed polysaccharide as a superdisintegrant 95
Table 3 – Precompression parameters of powder blend
Formulation code Parameters
Angle of repose () Bulk density (g/cm3) Tapped density (g/cm3) Carr’s index (%) Hausner’s ratio
F1 30.15 ± 1.21 0.50 ± 0.005 0.646 ± 0.009 22.67 ± 1.40 1.28 ± 0.025
F2 29.20 ± 0.42 0.508 ± 0.002 0.637 ± 0.0098 20.37 ± 1.61 1.24 ± 0.031
F3 28.78 ± 1.29 0.493 ± 0.03 0.654 ± 0.012 24.7 ± 1.66 1.32 ± 0.030
F4 28.03 ± 1.20 0.491 ± 0.015 0.651 ± 0.009 24.54 ± 0.78 1.32 ± 0.015
F5 27.65 ± 1.27 0.522 ± 0.003 0.649 ± 0.008 19.55 ± 1.40 1.23 ± 0.025
F6 26.28 ± 0.91 0.515 ± 0.005 0.635 ± 0.005 18.89 ± 0.39 1.22 ± 0.005
F7 30.84 ± 0.81 0.547 ± 0.003 0.627 ± 0.004 13.12 ± 0.005 1.14 ± 0.010
F8 29.20 ± 1.78 0.539 ± 0.003 0.629 ± 0.004 14.39 ± 0.54 1.16 ± 0.005
Results are presented as mean±SD, n=5.









F1 2.43 ± 0.11 4.56 ± 0.208 0.68 ± 0.01 200.2 ± 0.63
F2 2.33 ± 0.15 4.40 ± 0.173 0.71 ± 0.01 200.2 ± 0.61
F3 2.46 ± 0.05 4.43 ± 0.11 0.77 ± 0.01 199.7 ± 1.05
F4 2.40 ± 0.12 4.2 ± 0.251 0.79 ± 0.01 200.5 ± 1.35
F5 2.2 ± 0.11 4.33 ± 0.15 0.49 ± 0.015 200.2 ± 0.63
F6 2.23 ± 0.20 4.53 ± 0.05 0.57 ± 0.017 200.2 ± 0.61














TF8 2.26 ± 0.014 4.3 ± 0.0
All values are presented as mean±S D, n=5 a/20 b.
nd 1064.71 cm−1. The complex region of 900–600 cm−1 indi-
ates skeletal vibration and an aromatic ring in the drug
tructure. The weights of all the prepared tablets were within
he acceptable limits for uncoated tablets as per the United
tates Pharmacopoeia. The results of precompression param-
ter evaluation indicated good free ﬂowing properties of the
owder blend (Table 3).
The hardness of tablets was determined and was found to
e in the range of 4.20–4.56kg/cm2. Friability was observed
o be between 0.49% and 0.79%, which was less than 1%,
ndicating that the tablets had a good mechanical resis-
ance. The percentage drug content of all the formulations
as found to be between 98.36% w/w and 100.04% w/w.
he results of postcompression parameters are summarized
Table 5 – Postcompression parameters of orodispersible tablets
Formulation code
In vitro disintegration time (s) a Wetting
(s) a
F1 60.27 ± 0.62 46.73 ± 0
F2 57.29 ± 0.62 42.39 ± 0
F3 47.68 ± 0.53 37.05 ± 0
F4 32.34 ± 0.78 26.2 ± 0
F5 70.56 ± 1.82 54.17 ± 0
F6 61.32 ± 0.58 50.46 ± 0
F7 55.16 ± 1.44 47.90 ± 0
F8 46.96 ± 0.70 39.18 ± 0
All values are presented as mean±SD, n=6 a/10 b.0.70 ± 0.015 200.5 ± 1.35
in Tables 4 and 5. The wetting time and water absorption
ratio are important criteria for understanding the capacity
of a disintegrant to swell in the presence of a small amount
of water. The wetting time for all formulations was found
to be between 26.2±0.25 seconds and 54.17±0.48 seconds
(Table 5). The in vitro disintegration time for formulations
F1 to F8 is summarized in Table 5. The in vitro drug release
rate from the formulations containing polysaccharide was
found to be rapid as compared to the formulations contain-
ing SSG. The in vitro drug release proﬁles of the formulations
F1 to F8 are represented in Figs. 2 and 3. The results of
the stability study indicated that there was no signiﬁcant
change in the physical and chemical characteristics of the
tablet, and the optimized formulation F4 containing 7.5%
of valsartan
Parameters
time Water absorption ratio a Drug content b
.39 110.88 ± 0.24 100.00 ± 002
.35 119.04 ± 0.33 99.86 ± 0.1
.56 126.80 ± 1.02 99.81 ± 0.18
.25 133.55 ± 0.28 98.36 ± 0.43
.48 99.67 ± 0.49 98.54 ± 0.85
.76 99.24 ± 0.24 99.5 ± 0.77
.44 104.66 ± 0.70 99.84 ± 0.33
.43 109.52 ± 0.99 100.04 ± 0.20
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Fig. 2 – In vitro drug release proﬁle of formulations (F1–F4 and marketed formulation).
proFig. 3 – In vitro drug release
of polysaccharide was stable at 40◦ C/75% RH for 3 months
(Table 6).
4. Discussion
Itwas reported that seeds ofC. tora contain galactomannans.35
Certain gums having galactomannan such as locust bean
gum and Guar gum have been used as superdisintegrants.35,36
Hence, on a similar basis, C. tora gum has been stud-
ied for its superdisintegrant property. It was observed that
C. tora has good swelling properties.37 Therefore, we have
attempted to develop ODTs frompolysaccharide isolated from
the seeds of C. tora in order to investigate its potential as
Table 6 – Stability study data for F4 batch
Parameters 1 mo
Hardness (kg/cm2) 4.08 ± 0.09
% Friability 0.76 ± 0.09
Drug content (%) 99.53 ± 0.45
Disintegration time(s) 31.84 ± 0.6ﬁle of formulations (F5–F8).
a superdisintegrant. There are various reported mechanisms
of superdisintegrants such as swelling, wicking, deformation,
and electrostatic repulsion.38 ODTs of valsartanwere prepared
by direct compression method using different concentrations
of C. tora gum as a natural disintegrant and SSG as a synthetic
superdisintegrant in the same concentration. The excipients
were selected depending on preformulation studies, and their
concentrations were established on the basis of an extensive
literature survey. Microcrystalline cellulose was selected as a
directly compressible diluent.39 Aspartame was selected as a
40sweetening agent, and vanilla was used as ﬂavor. Because
a direct compression method was used for the preparation of
tablets, magnesium stearate was chosen as the lubricant to
improve the ﬂow properties of the blend.41
2 mo 3 mo
4.22 ± 0.1 4.1 ± 0.12
0.79 ± 0.03 0.77 ± 0.05
100.3 ± 0.1 99.95 ± 0.19
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Tablets prepared using polysaccharide isolated from C. tora
ook a lesser time for wetting of the tablet as compared to
he formulations containing SSG. This might be attributable
o the rapid penetration of water into the pores of the tablets.
he water absorption ratio of polysaccharide was higher com-
ared to that of SSG. It was observed that thewater absorption
atio increased with an increase in the concentration of the
uperdisintegrant. Because of their higher swelling property,
ormulations containing polysaccharide disintegrated quickly
nd completely as compared to formulations containing SSG.
rapid increase in the dissolution of drugs with an increase
n polysaccharide content may be attributed to the swelling of
he polysaccharide powder, which leads to the penetration of
ater in the pores of the tablets and the generation of hydro-
ynamic pressure for a quick and complete disintegration of
ablets. However, in the case of tablets prepared by SSG, disin-
egration takes place by the rapid uptake of water followed by
uick and enormous swelling into smaller particles, but dis-
olution occurs slowly owing to the formation of a viscous gel
ayer by SSG.42
The drug release of F4 formulation was rapid and better
ompared to the marketed formulations. The formulation F4
ontaining 7.5% of polysaccharide showed a rapid wetting
ime and disintegration time as compared with the formula-
ion prepared using a synthetic superdisintegrant at the same
oncentration level. Hence, batch F4 was considered the opti-
ized formulation.
In conclusion, the present work revealed that C. tora
eed polysaccharide is a potential candidate for use as a
isintegrant in the formulation of ODTs. Because C. tora
olysaccharide is inexpensive compared to synthetic super-
isintegrants, nontoxic, compatible, and easy tomanufacture,
t can be used in place of commercially available synthetic
uperdisintegrants. The prepared tablets also offer further
dvantages in terms of patient compliance, quick onset of
ction, high bioavailability, and good stability, all of which
ake these tablets a better dosage form for the treatment of
ypertension.
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